Ventyx Biosciences ( NASDAQ:VTYX – Get Rating ) ‘s stock had its 'reiterates' rating reaffirmed by investment analysts at 500.com in a report released on Friday, Benzinga reports. A number of other equities analysts have also weighed in on VTYX. Wells Fargo & Company assumed coverage on Ventyx Biosciences in a research note on Monday, March 20th. They set an 'overweight' rating and a $77.00 price objective for the company. Canaccord Genuity Group raised their target price on Ventyx Biosciences from $35.

https://www.dailypolitical.com/2023/05/15/ventyx-biosciences-nasdaqvtyx-stock-rating-reaffirmed-by-500-com.html

#dailypolitical